Tumour suppressor candidate 3 inhibits biological function and increases endoplasmic reticulum stress of melanoma cells WM451 by regulating AKT/GSK3‐β/β‐catenin pathway

TP53 Tumor-suppressor Gene Plays a Key Role in IGF1 Signaling Pathway Related to the Aging of Human Melanocytes

(2019) HYEJU KO et al.   ANTICANCER RESEARCH

Modulating PKCα Activity to Target Wnt/β-Catenin Signaling in Colon Cancer

(2019) Sébastien Dupasquier et al.   Cancers

Embryonic stem cell microenvironment suppresses the malignancy of cutaneous melanoma cells by down‐regulating PI3K/AKT pathway

(2019) Chenjie Wang et al.   Cancer Medicine

Retinoblastoma binding protein 4 up-regulation is correlated with hepatic metastasis and poor prognosis in colon cancer patients

(2019) Yan-Dong Li et al.   Hepatobiliary & Pancreatic Diseases International

Senescent human melanocytes drive skin ageing via paracrine telomere dysfunction

(2019) Stella Victorelli et al.   EMBO JOURNAL

Three-generation family with novel contiguous gene deletion on chromosome 2p22 associated with thoracic aortic aneurysm syndrome

(2018) Bianca Quiñones-Pérez et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

Expression of TUSC3 and its Prognostic Significance in Colorectal Cancer

(2018) Zhu Yu Feng et al.   PATHOLOGY RESEARCH AND PRACTICE

TUSC3 accelerates cancer growth and induces epithelial-mesenchymal transition by upregulating claudin-1 in non-small-cell lung cancer cells

(2018) Siyang Feng et al.   EXPERIMENTAL CELL RESEARCH

Tumor Suppressor Candidate 1 Suppresses Cell Growth and Predicts Better Survival in Glioblastoma

(2016) Rui Zhang et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

TUSC3 promotes colorectal cancer progression and epithelial-mesenchymal transition (EMT) through WNT/β-catenin and MAPK signalling

(2016) Ye Gu et al.   JOURNAL OF PATHOLOGY

TUSC3 suppresses glioblastoma development by inhibiting Akt signaling

(2016) Zhenfeng Jiang et al.   TUMOR BIOLOGY

Tumor suppressor candidate 3 as a novel predictor for lymph node metastasis in lung cancer patients

(2016) Xinshuang Yu et al.   Oncology Letters

Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and Metastasis

(2016) Xiaoqiang Fan et al.   PLoS One

Association of TUSC3 gene polymorphisms with non-syndromic mental retardation based on nuclear families in the Qinba mountain area of China

(2015) M.J. Zhang et al.   GENETICS AND MOLECULAR RESEARCH

Tumor suppressor candidate 3 (TUSC3) prevents the epithelial-to-mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cells

(2015) Kateřina Kratochvílová et al.   INTERNATIONAL JOURNAL OF CANCER

Identification of FLOT2 as a novel target for microRNA-34a in melanoma

(2014) Rui Liu et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

TUSC3 Loss Alters the ER Stress Response and Accelerates Prostate Cancer Growth in vivo

(2014) Peter Horak et al.   Scientific Reports

Loss of the oligosaccharyl transferase subunit TUSC3 promotes proliferation and migration of ovarian cancer cells

(2013) PETR VAŇHARA et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Methylation status ofTUSC3is a prognostic factor in ovarian cancer

(2012) Dietmar Pils et al.   CANCER

Ischemic Postconditioning Mediates Cardioprotection Via PI3K/GSK-3β/β-Catenin Signaling Pathway in Ischemic Rat Myocardium

(2012) Qiao-ling Wu et al.   SHOCK

Cadmium induces carcinogenesis in BEAS-2B cells through ROS-dependent activation of PI3K/AKT/GSK-3β/β-catenin signaling

(2012) Young-Ok Son et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Role of Wnt/β-catenin signaling in liver metabolism and cancer

(2009) Satdarshan Pal Singh Monga   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Melanoma and the tumor microenvironment

(2008) Jessie Villanueva et al.   Current Oncology Reports